MedTrace Logo

Prognostic Indicators as Provided by the EPIC ClearView

NCT01476995 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 353

Last updated 2011-11-22

No results posted yet for this study

Summary

The objective of this study is to determine whether the finger tip images captured by the EPIC ClearView device, when analyzed via the ClearView software, produce a Response Scale that characterizes trends consistent with known diagnoses identified by medical doctors. Specifically, the investigators hypothesize that the organ system involving any of a series of known active diagnoses will be identified in the EPIC ClearView Response Scale report with the intention of providing potential triage capabilities.

Conditions

Sponsors & Collaborators

  • Epic Research & Diagnostics, Inc.

    lead INDUSTRY

Principal Investigators

  • Clair A Francomano, MD · Greater Baltimore Medical Center

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01476995 on ClinicalTrials.gov